[pending] CELECOXIB (CELECOXIB)
Pending LLM rewrite. Source: FDA_DRUG D-0459-2025.
- Product
- CELECOXIB — CELECOXIB (CELECOXIB)
- Category
- Drug
- Distribution
- Distributed nationwide
Category
FDA recalls of prescription and over-the-counter drugs.
FDA drug recalls cover prescription medicines, over-the-counter products, biologic and gene therapies, and active pharmaceutical ingredients (the raw drug substances that manufacturers compound into finished products). Recall classifications follow the same Class I / II / III system as food, and most published recalls are Class II — the product is unlikely to cause permanent harm but doesn't meet specification.
The most common reasons for a drug recall are out-of-specification potency or dissolution (the active ingredient is present in too high or too low a dose), microbial contamination, particulate matter in injectables, mix-ups during packaging where bottles end up with the wrong tablets, and nitrosamine impurities in certain drug classes. Many drug recalls are at the lot level — the manufacturer's whole product line is still safe to use, but specific production lots are pulled.
If a recall affects your medication: don't stop taking it on your own. Call your prescriber or pharmacist before doing anything. Stopping a prescribed drug abruptly can be more dangerous than the issue prompting the recall. Most drug-recall remedies route through the dispensing pharmacy, who'll either swap your supply for an unaffected lot or coordinate a refund with the manufacturer.
Pending LLM rewrite. Source: FDA_DRUG D-0459-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0488-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0497-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0467-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0466-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0465-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0468-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0462-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0470-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0463-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0458-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0454-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0457-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0456-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0455-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0452-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0449-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0453-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0447-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0451-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0448-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0450-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0438-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0439-2025.
Pending LLM rewrite. Source: FDA_DRUG D-0424-2025.
Looking for a different category? Browse all recalls.